Use of hyperbaric oxygen therapy for preventing delayed neurological sequelae in patients with carbon monoxide poisoning: A multicenter, prospective, observational study in Japan
Authors:
Open Access
- 18 June 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (6) , e0253602
Abstract
Background: The purpose of this study was to clarify the practical clinical treatment for acute carbon monoxide (CO) poisoning in Japan and to investigate the efficacy of hyperbaric oxygen (HBO2) therapy in preventing delayed neurological sequelae (DNS) in the acute phase of CO poisoning. Methods: We conducted a multicenter, prospective, observational study of acute CO poisoning in Japan. Patients with acute CO poisoning were enrolled and their treatment details were recorded. The primary endpoint was the onset of DNS within 2 months of CO exposure. Factors associated with DNS were assessed with logistic regression analysis. Results: A total of 311 patients from 57 institutions were registered and 255 were analyzed: 171 received HBO2 therapy (HBO2 group) and 84 did not (normobaric oxygen [NBO2] group). HBO2 therapy was performed zero, once, twice, or three times within the first 24 h in 1.8%, 55.9%, 30.9%, and 11.3% of the HBO2 group, respectively. The treatment pressure in the first HBO2 session was 2.8 ATA (47.9% of the HBO2 group), 2.0 ATA (41.8%), 2.5 ATA (7.9%), or another pressure (2.4%). The incidence of DNS was 13/171 (7.6%) in the HBO2 group and 3/84 (3.6%) in the NBO2 group (P = 0.212). The number of HBO2 sessions in the first 24 h was one of the factors associated with the incidence of DNS (odds ratio, 2.082; 95% confidence interval, 1.101–3.937; P = 0.024). Conclusions: The practical clinical treatment for acute CO poisoning, including HBO2 therapy, varied among the institutions participating in Japan. HBO2 therapy with inconsistent protocols showed no advantage over NBO2 therapy in preventing DNS. Multiple HBO2 sessions was associated with the incidence of DNS.Keywords
This publication has 39 references indexed in Scilit:
- Variability in Treatment for Carbon Monoxide Poisoning in Japan: A Multicenter Retrospective SurveyEmergency Medicine International, 2018
- The use of hyperbaric oxygen therapy for carbon monoxide poisoning in Europe.2016
- Variability in hyperbaric oxygen treatment for acute carbon monoxide poisoning.2012
- Hyperbaric oxygen for carbon monoxide poisoningCochrane Database of Systematic Reviews, 2011
- Hyperbaric oxygen therapy for acute domestic carbon monoxide poisoning: two randomized controlled trialsIntensive Care Medicine, 2010
- Hyperbaric Oxygen for Acute Carbon Monoxide PoisoningNew England Journal of Medicine, 2002
- Hyperbaric or normobaric oxygen for acute carbon monoxide poisoning: a randomised controlled clinical trialMedical Journal of Australia, 1999
- 1996 Undersea and Hyperbaric Medical Society annual scientific meeting. Anchorage, Alaska, 20 April-1-5 May 1996. Abstracts.1996
- Delayed Neuropsychologic Sequelae After Carbon Monoxide Poisoning: Prevention by Treatment With Hyperbaric OxygenAnnals of Emergency Medicine, 1995
- TRIAL OF NORMOBARIC AND HYPERBARIC OXYGEN FOR ACUTE CARBON MONOXIDE INTOXICATIONThe Lancet, 1989